The slip
PARKINSON RECEIPTno. 17251
01 Nov 2026, 10:36 UTCdopamine neurons, braak
predictionERBIN in dopamine neurons tracks Braak Lewy-body stage
registeredfe899111c4265ad1
discovery+0.44 p=0.240 n=9
replication+0.11 p=0.773 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.44, p 0.240)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT09526715a1386cf5197cd0b3…
follows 0f25aa1c73f9…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 17251: ERBIN in dopamine neurons, braak
- power
- full sample +0.26 (p 0.302, n 18), 95% CI -0.24 to +0.65. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.23 (p 0.369, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.40 (p 0.101, n 18). could be the mix.
- skeptic
- leave-one-out range +0.16 to +0.37, sign flips 0; without severely affected donors +0.26 (p 0.302, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ERBIN in dopamine neurons.
case closed: nothing better to follow up.